< Back to previous page

Project

African network to study, treat and prevent onchocerciasis associated epilepsy (OAE-Africa).

Recently, the consortium involved in this project collected strong clinical and epidemiological evidence that nodding syndrome is one of the clinical presentations of onchocerciasis (river blindness)-associated epilepsy (OAE) and that this form of epilepsy is preventable by strengthening onchocerciasis elimination programs. Despite this evidence there is still little awareness about the important public health problem caused by OAE and a complete lack of interventions to address the problem. Eight African partners of the Democratic Republic Congo, Uganda and Tanzania, all with complementary OAE expertise, will be involved in the project. By increas-ing their research capacity and through multi-country studies we hope to solve the remaining OAE research questions. Moreover, by joining forces, including the organisation of a high profile international workshop on OAE, we aim to put OAE on the international development agenda. This project will increase OAE awareness among affected communities, local health care workers, health policymakers and hopefully funders in order to take appropriate actions.
Date:1 Jan 2019 →  31 Aug 2022
Keywords:FOCUS GROUP
Disciplines:Neurological and neuromuscular diseases, Tropical medicine, Health promotion and policy, Preventive medicine, Public health care not elsewhere classified
Project type:Collaboration project